Expion360 Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2022. The filing identifies the registrant as Expion360 Inc. (NASDAQ: XPON); the request metadata names Expion Energy, Inc., so the entity should be confirmed.
Business context and financial results
Expion360 designs, assembles, and distributes lithium iron phosphate batteries and accessories, primarily for RV and marine customers. It is developing home energy storage and other markets. The company completed its IPO on April 1, 2022.
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Net sales | $1.38 million | $1.33 million | $5.74 million | $3.21 million |
| Gross profit / margin | $403,000 / 29.1% | $534,000 / 40.1% | $1.97 million / 34.3% | $1.19 million / 36.9% |
| Operating loss | $1.26 million | $191,000 | $4.51 million | $275,000 |
| Net loss | $1.28 million | $353,000 | $6.07 million | $730,000 |
| Basic and diluted loss per share | $0.19 | $0.13 | $1.03 | $0.28 |
Cash, debt, and liquidity
- Cash and cash equivalents were $8.12 million at September 30, 2022, versus $773,000 at December 31, 2021. Current assets exceeded current liabilities by approximately $12.82 million.
- Nine-month operating cash outflow was $4.70 million, compared with $2.77 million in 2021; investing outflow was $383,000. Financing provided $12.43 million, including $14.77 million of net IPO proceeds, partly offset by debt repayments.
- At quarter-end, long-term debt was $524,000, shareholder promissory notes were $825,000, and operating lease liabilities totaled $3.34 million. The $550,000 working-capital loans and approximately $2.46 million of high-interest debt were repaid in April 2022; the future-revenue financing liability was also fully repaid.
- Inventory was $5.04 million, up from $2.05 million at year-end 2021. The company reported no material off-balance-sheet arrangements.
Changes versus the prior comparable periods
- Sales increased 3.9% in Q3 and 78.9% for the first nine months, attributed to higher sales volume, expanded products, and distribution.
- Gross margin fell 11.0 percentage points in Q3 and 2.6 points year to date. Management cited higher facility and labor costs and landed costs.
- SG&A increased 129% in Q3 and 344% year to date. Nine-month expense included $2.11 million of non-cash stock compensation and higher staffing, professional, marketing, facility, and IPO-related costs.
- Nine-month interest expense rose to $1.57 million, including $1.20 million of non-cash debt-discount amortization. The company reported $3.3 million of non-cash expenses within its $6.07 million nine-month net loss.
Outlook, commentary, and risks
- Management said IPO proceeds and expected operating cash flows should fund working capital, capital spending, and debt service for at least 12 months. It also said further capital may be needed to support expansion and its longer-term plan; availability and terms are uncertain. The filing provides no formal revenue or earnings guidance.
- Management planned to build in-house assembly capacity in Redmond, Oregon, with up to $950,000 of 2022 spending anticipated for facilities and assembly-line expansion. It expected onshore semi-automated pack assembly to begin in Q4 2022. A distribution center in Indiana became operational during Q1.
- Approximately 92% of inventory purchases in the first nine months came from suppliers in China and Hong Kong; foreign-supplier lead times can reach 120 days and require prepayment. A Denmark-based secondary cell source was secured, but supply-chain, port, freight, and raw-material disruptions remain risks.
- The company disclosed recurring losses and negative operating cash flow. Its risk factors refer to substantial doubt about its ability to continue as a going concern in prior audited financial statements; management’s current view is that available resources are sufficient for at least 12 months after issuance.
- Other risks include competition and pricing pressure, customer and channel concentration, product quality or liability claims, COVID-19 and broader economic uncertainty, and the ability to achieve planned operating efficiencies. Two customers represented approximately 29% of Q3 sales combined. No material legal proceedings were reported, and management estimated no warranty liability.
- Management reported disclosure controls were effective at a reasonable-assurance level and no material change in internal control over financial reporting during the period.
Important facts for investors to verify
- Confirm the registrant identity: this filing is for Expion360 Inc., not an entity named Expion Energy, Inc.
- Assess whether sales growth can translate into improved gross margins and operating cash flow as expansion costs continue.
- Track inventory levels, sell-through, supplier prepayments, China/Hong Kong exposure, and progress diversifying cell supply.
- Review the assumptions behind management’s 12-month liquidity assessment, planned capital expenditures, and any future financing needs.
- Reconcile the warrant disclosures: the filing reports 858,436 warrants outstanding in one passage, while its detailed warrant/options table lists 888,436 combined warrants and non-plan options; the share-reserve total is 1,717,936.
- Monitor potential dilution: 1,717,936 shares were reported reserved for warrants and options, in addition to the 6,802,464 common shares outstanding at September 30, 2022.